Schrodinger Inc (SDGR)
Fixed asset turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|
Revenue | US$ in thousands | 216,666 | 180,955 | 137,931 | 108,095 |
Property, plant and equipment | US$ in thousands | 41,475 | 14,244 | 10,025 | 5,140 |
Fixed asset turnover | 5.22 | 12.70 | 13.76 | 21.03 |
December 31, 2023 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $216,666K ÷ $41,475K
= 5.22
Schrodinger Inc's fixed asset turnover has shown a declining trend over the past five years, from 13.65 in 2019 to 9.29 in 2023. This indicates that the company is generating less revenue for each dollar invested in fixed assets. A lower fixed asset turnover ratio could signify inefficiency in asset utilization or potential underperformance in sales. It is essential for the company to closely monitor and assess its asset management strategies and operations to improve the efficiency of its fixed asset utilization and overall financial performance.
Peer comparison
Dec 31, 2023
Company name
Symbol
Fixed asset turnover
Schrodinger Inc
SDGR
5.22
Abbott Laboratories
ABT
3.88
AbbVie Inc
ABBV
10.89
Alkermes Plc
ALKS
7.23
Amphastar P
AMPH
2.28
ANI Pharmaceuticals Inc
ANIP
10.19
Arcus Biosciences Inc
RCUS
2.29
Biomarin Pharmaceutical Inc
BMRN
2.23
Bristol-Myers Squibb Company
BMY
6.77
Catalent Inc
CTLT
1.20
Catalyst Pharmaceuticals Inc
CPRX
333.23